DeepWise
PrivateLast Round
VC Round
Jan 24, 2025
Total Funding Raised
$46.2M
Company Overview
DeepWise operates in Healthcare & Life Sciences and is based in Beijing. Its latest recorded funding round was a VC Round in January 2025.
DeepWise is a healthcare technology company that develops artificial intelligence-assisted diagnosis systems and medical imaging software to improve diagnostic accuracy and efficiency for diseases such as lung cancer, breast cancer, and stroke.
Sector
Healthcare & Life Sciences
Verticals
Medical Imaging, Medical AI, Computer Vision, Healthcare Analytics
Business Model
B2B
Customer Profile
Government Contracts, Subscription SaaS, Services & Consulting, Hardware + Subscription
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
DeepWise Comparables
Compare DeepWise with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Infervision | 89% | |
| HY Medical | 85% | |
| VoxelCloud | 84% |
For institutional investors. Book with your work email.
DeepWise Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Jan 24, 2025 | ||||
| Series C Extension | May 11, 2021 | ||||
| Series C Extension | Dec 15, 2020 | ||||
| Series C | Jun 10, 2019 | ||||
| Series B | Apr 2, 2018 | ||||
Series A Extension | Nov 13, 2017 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
DeepWise Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Legend Star | Series B, Series C |
| Dalton Venture | Series A Extension |
| Hongdao Capital | Series B, Series A Extension |
| Tongdu Capital | Series B, Series C, Series A Extension |
| Legend Capital | Series C Extension, Series C, Series B, VC Round |
| CITIC Private Equity Funds Management | Series C Extension |
| Silk Road Huachuang | Series C |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 13, 2017
$17.3M round led by DHVC and Vertex Ventures China.
- Mar 1, 2017
$5.1M round led by FengHe Group and Hongtai Fund.
For institutional investors. Book with your work email.
DeepWise Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about DeepWise's valuation, stock price, and market status.
Is DeepWise a public or private company?
DeepWise is a private company.
What is the current stock price of DeepWise?
DeepWise is a private company, so its shares have no public market price. Caplight tracks DeepWise's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is DeepWise worth (valuation)?
Valuation information for DeepWise is not publicly available.
Can I buy DeepWise stock?
DeepWise shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was DeepWise's last funding round?
DeepWise's most recent funding round was VC Round on January 24, 2025.
Who are the main investors in DeepWise?
Key investors in DeepWise include Legend Capital, CITIC Private Equity Funds Management, Sunshine Insurance Group, Zhongguancun Longmen Investment, DHVC.
Will DeepWise IPO soon?
No public IPO plans have been announced for DeepWise.
How can I track DeepWise secondary market activity?
Caplight tracks bids, offers, and trades in DeepWise's shares on secondary markets.